Company Filing History:
Years Active: 2016
Title: Marie-Helene DeGrave: Innovator in Pharmaceutical Composition
Introduction
Marie-Helene DeGrave is a notable inventor based in Lille, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled-release oral compositions. Her innovative work has the potential to enhance drug delivery systems and improve patient outcomes.
Latest Patents
Marie-Helene DeGrave holds 1 patent for her invention titled "Modified starch derivative-based matrix for colon targeting." This patent describes a controlled-release oral pharmaceutical composition that includes a lipophilic matrix and a hydrophilic matrix. The invention aims to disperse an active ingredient within these matrices, providing a novel approach to drug delivery.
Career Highlights
Marie-Helene DeGrave is associated with Roquette Freres, a company known for its expertise in food and pharmaceutical ingredients. Her work at Roquette Freres has allowed her to focus on innovative solutions that address the needs of the pharmaceutical industry.
Collaborations
Throughout her career, Marie-Helene has collaborated with esteemed colleagues such as Olaf Haeusler and Daniel Wils. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.
Conclusion
Marie-Helene DeGrave's contributions to the field of pharmaceuticals exemplify her dedication to innovation and improvement in drug delivery systems. Her work continues to influence the industry and pave the way for future advancements.